Bannerman Opens Etango Heap Leach Demonstration Plant

Bannerman Resources Limited ("Bannerman") is pleased to confirm the successful completion of the construction and official opening on 24 March 2015 of the Etango Heap Leach Demonstration Plant ("Demonstration Plant") by Mr Patrick Elungu, Chief Inspector - Regional Services, Ministry of Mines and Energy and Dr Wotan Swiegers, Director of the Namibian Uranium Institute.

The full report is available on Bannerman's website at www.bannermanresources.com and on SEDAR (www.sedar.com).

The commissioning of the Demonstration Plant is a significant milestone as Bannerman continues to progress the development of the Etango Project. The operation of the Demonstration Plant, an integral step of the detailed engineering and financing phases, specifically enables:

  • Demonstrating the design and projected performance reflected in the Definitive Feasibility Study,
  • Maintaining and building project knowledge, and
  • Pursuing value engineering.

Bannerman's Chief Executive Office, Len Jubber, said:

"The commissioning of the Demonstration Plant coincides with the Chinese government approving construction of two more units at the Hongyanhe nuclear power plant in Liaoning province, marking the first approval for new reactors in four years.

China, currently the largest constructor of new reactors clearly continues to ramp up its nuclear energy program in line with its stated goal of increasing electricity generated from nuclear plants from 21 GW currently to 58 GW by 2020 and 150 GW by 2030. In terms of reactors, China now has 24 reactors in operation, 25 under construction and 189 on order, planned or proposed.

In the face of this growing demand, Bannerman's advancing Etango Project remains one of the very few globally significant uranium projects that can realistically be brought into production in the medium term".

Len Jubber, Chief Executive Officer

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.